Category: testosterone

NEW IMS Symposium with Dr James Simon & Sharon Parish

Sexual Health and Treatment for Women: Fact, Fiction, the Future. At the International Menopause Society’s 19th World Congress on Menopause to be held 19th – 22nd October 2024 in… Continue Reading →

Read more

BMS: Menopause: Misinformation and Management

The conversation around menopause is getting louder but there is still a lot of misinformation.  British Menopause Society medical professionals dispel menopause misinformation, talk… Continue Reading →

Read more

World Menopause Day – 18th October

The theme for World Menopause Day 2023 is Cardiovascular Disease World Menopause Day is held every year on the 18th October. The purpose of the… Continue Reading →

Read more

In Australia, is Addyi (Flibanserin) available or what is available?

Flibanserin, the drug that gives women one extra sexually satisfying experience every two months. The United States Food and Drug Administration (FDA) approved the… Continue Reading →

Read more

Monash University – New study to see whether a skin cream can prevent heart failure in women

   

Read more

Find A Doctor Who Knows Menopause

Find an AMS doctor To help you find a doctor who is right for you, the AMS has assembled this search feature of AMS… Continue Reading →

Read more

AndroFeme 1 licensed for hypoactive sexual desire dysfunction in postmenopausal women

Lawley Pharmaceuticals  has obtained approval for registration of AndroFeme® 1 in the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →

Read more

Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1

Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →

Read more

Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1

Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →

Read more

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019  — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →

Read more